peoplePerson
Ash A. Alizadeh
Co-invented the CAPP-Seq method for reading tumour DNA in blood and used it to track lymphoma and lung cancer.
Ash Alizadeh is an oncologist and computational biologist. Alizadeh co-developed CAPP-Seq and phased variant enrichment for ultrasensitive ctDNA detection, applied to minimal residual disease in lymphoma and lung cancer, and led early work on tumour cell-of-origin classification in DLBCL.
Role
Professor of Medicine (Oncology), Stanford University
Specialisms
Circulating tumour DNALymphomaComputational oncology
| Title | Journal | Year |
|---|---|---|
| An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage | Nature Medicine | 2014 |
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Nature | 2000 |